GlassScriptPhysician profile
Adnan Khan
NPI 1952807794
$3,530.72
in general payments reported to CMS, 2019-2025
10 companies · $49.74 in 2025
The $49.74 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.50 · 2022: $721 · 2023: $1,635 · 2024: $1,097 · 2025: $49.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,754 · Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,754.33 |
| Food and Beverage | $1,027.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,827.74 | 2023-2024 | Disposable Distal Attachment, Visiglide, Single Use Electrosurgical Knife Kd-655 |
| Abbvie INC. | $950.78 | 2021-2024 | |
| Gilead Sciences, INC. | $276.24 | 2022-2024 | |
| Boston Scientific Corporation | $117.43 | 2023-2025 | Exalt Model D, General - Biliary Devices |
| Takeda Pharmaceuticals U.S.A., INC. | $107.86 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Mallinckrodt Hospital Products INC. | $77.53 | 2023 | Terlivaz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.44 | 2022-2023 | Trulance |
| Conmed Corporation | $33.18 | 2025 | Conmed Biliary |
| Olympus America INC. | $14.52 | 2023 | Endocuff Vision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.